68 related articles for article (PubMed ID: 8649790)
21. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
Lyne JC; Melhem MF; Finley GG; Wen D; Liu N; Deng DH; Salup R
Cancer J Sci Am; 1997; 3(1):21-30. PubMed ID: 9072304
[TBL] [Abstract][Full Text] [Related]
22. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin.
Sliwkowski MX; Schaefer G; Akita RW; Lofgren JA; Fitzpatrick VD; Nuijens A; Fendly BM; Cerione RA; Vandlen RL; Carraway KL
J Biol Chem; 1994 May; 269(20):14661-5. PubMed ID: 7514177
[TBL] [Abstract][Full Text] [Related]
23. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
Pan MH; Lin CC; Lin JK; Chen WJ
J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
[TBL] [Abstract][Full Text] [Related]
24. An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells.
Grant SL; Hammacher A; Douglas AM; Goss GA; Mansfield RK; Heath JK; Begley CG
Oncogene; 2002 Jan; 21(3):460-74. PubMed ID: 11821958
[TBL] [Abstract][Full Text] [Related]
25. Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancer.
Mitsui K; Yonezawa M; Tatsuguchi A; Shinji S; Gudis K; Tanaka S; Fujimori S; Sakamoto C
BMC Cancer; 2014 Nov; 14():863. PubMed ID: 25416285
[TBL] [Abstract][Full Text] [Related]
26. Cytotoxic activity of chimeric toxins containing the epidermal growth factor-like domain of heregulins fused to PE38KDEL, a truncated recombinant form of Pseudomonas exotoxin.
Kihara A; Pastan I
Cancer Res; 1995 Jan; 55(1):71-7. PubMed ID: 7805044
[TBL] [Abstract][Full Text] [Related]
27. Formation of a high affinity heregulin binding site using the soluble extracellular domains of ErbB2 with ErbB3 or ErbB4.
Fitzpatrick VD; Pisacane PI; Vandlen RL; Sliwkowski MX
FEBS Lett; 1998 Jul; 431(1):102-6. PubMed ID: 9684874
[TBL] [Abstract][Full Text] [Related]
28. Involvement of the neuregulins and their receptors in cardiac and neural development.
Carraway KL
Bioessays; 1996 Apr; 18(4):263-6. PubMed ID: 8967893
[TBL] [Abstract][Full Text] [Related]
29. The structural basis for the specificity of epidermal growth factor and heregulin binding.
Barbacci EG; Guarino BC; Stroh JG; Singleton DH; Rosnack KJ; Moyer JD; Andrews GC
J Biol Chem; 1995 Apr; 270(16):9585-9. PubMed ID: 7721889
[TBL] [Abstract][Full Text] [Related]
30. Selection of heregulin variants having higher affinity for the ErbB3 receptor by monovalent phage display.
Ballinger MD; Jones JT; Lofgren JA; Fairbrother WJ; Akita RW; Sliwkowski MX; Wells JA
J Biol Chem; 1998 May; 273(19):11675-84. PubMed ID: 9565588
[TBL] [Abstract][Full Text] [Related]
31. Insulin regulates heregulin binding and ErbB3 expression in rat hepatocytes.
Carver RS; Sliwkowski MX; Sitaric S; Russell WE
J Biol Chem; 1996 Jun; 271(23):13491-6. PubMed ID: 8662847
[TBL] [Abstract][Full Text] [Related]
32. The v- and c-myc oncogene proteins colocalize in situ with small nuclear ribonucleoprotein particles.
Spector DL; Watt RA; Sullivan NF
Oncogene; 1987 Mar; 1(1):5-12. PubMed ID: 2963988
[TBL] [Abstract][Full Text] [Related]
33. The erbB3 gene product is a receptor for heregulin.
Carraway KL; Sliwkowski MX; Akita R; Platko JV; Guy PM; Nuijens A; Diamonti AJ; Vandlen RL; Cantley LC; Cerione RA
J Biol Chem; 1994 May; 269(19):14303-6. PubMed ID: 8188716
[TBL] [Abstract][Full Text] [Related]
34. Interaction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulin.
Yoo JY; Wang XW; Rishi AK; Lessor T; Xia XM; Gustafson TA; Hamburger AW
Br J Cancer; 2000 Feb; 82(3):683-90. PubMed ID: 10682683
[TBL] [Abstract][Full Text] [Related]
35. Receptor binding and biological activity of mammalian expressed sensory and motor neuron-derived factor (SMDF).
Osheroff PL; Tsai SP; Chiang NY; King KL; Li R; Lewis GD; Wong K; Henzel W; Mather J
Growth Factors; 1999; 16(3):241-53. PubMed ID: 10372964
[TBL] [Abstract][Full Text] [Related]
36. A potential autocrine loop between heregulin-alpha and erbB-3 receptor in human prostatic adenocarcinoma.
Leung HY; Weston J; Gullick WJ; Williams G
Br J Urol; 1997 Feb; 79(2):212-6. PubMed ID: 9052472
[TBL] [Abstract][Full Text] [Related]
37. Ligand-directed retroviral targeting of human breast cancer cells.
Han X; Kasahara N; Kan YW
Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9747-51. PubMed ID: 7568210
[TBL] [Abstract][Full Text] [Related]
38. Nuclear c-Myc: a molecular marker for early stage pemphigus vulgaris.
Williamson L; Hunziker T; Suter MM; Müller EJ
J Invest Dermatol; 2007 Jun; 127(6):1549-55. PubMed ID: 17315040
[No Abstract] [Full Text] [Related]
39. c-erbB-2 proto-oncogene product.
Battifora H
Histopathology; 1990 Jan; 16(1):105-6. PubMed ID: 1968419
[No Abstract] [Full Text] [Related]
40. Nuclear moonlighting of the secreted growth factor heregulin drives endocrine-resistant breast cancer independently of HER2/HER3 signaling.
Yang L; Vander Steen T; Espinoza I; Cuyàs E; Verdura S; Menendez JA; Lupu R
Am J Cancer Res; 2022; 12(5):2173-2188. PubMed ID: 35693067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
